Home LiteratureArticle Details
PMID: 10675335 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Regulation of E2F1 activity by acetylation.

The EMBO journal ·Vol. 19 ·No. 4 ·2000-02-15 ·Pages 662-71

Martínez-Balbás MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T

Abstract

During the G(1) phase of the cell cycle, an E2F-RB complex represses transcription, via the recruitment of histone deacetylase activity. Phosphorylation of RB at the G(1)/S boundary generates a pool of 'free' E2F, which then stimulates transcription of S-phase genes. Given that E2F1 activity is stimulated by p300/CBP acetylase and repressed by an RB-associated deacetylase, we asked if E2F1 was subject to modification by acetylation. We show that the p300/CBP-associated factor P/CAF, and to a lesser extent p300/CBP itself, can acetylate E2F1 in vitro and that intracellular E2F1 is acetylated. The acetylation sites lie adjacent to the E2F1 DNA-binding domain and involve lysine residues highly conserved in E2F1, 2 and 3. Acetylation by P/CAF has three functional consequences on E2F1 activity: increased DNA-binding ability, activation potential and protein half-life. These results suggest that acetylation stimulates the functions of the non-RB bound 'free' form of E2F1. Consistent with this, we find that the RB-associated histone deacetylase can deacetylate E2F1. These results identify acetylation as a novel regulatory modification that stimulates E2F1's activation functions.

MeSH Terms
Acetylation Acetyltransferases/metabolism Amino Acid Sequence Animals Base Sequence Binding Sites/genetics Carrier Proteins Cell Cycle Proteins/chemistry,genetics,metabolism Cell Line DNA/genetics,metabolism DNA-Binding Proteins E2F Transcription Factors E2F1 Transcription Factor G1 Phase Histone Acetyltransferases Histone Deacetylases/metabolism Humans In Vitro Techniques Molecular Sequence Data Mutagenesis, Site-Directed Nuclear Proteins/metabolism Retinoblastoma Protein/metabolism Retinoblastoma-Binding Protein 1 S Phase Sequence Homology, Amino Acid Trans-Activators/metabolism Transcription Factor DP1 Transcription Factors/chemistry,genetics,metabolism Transcriptional Activation p300-CBP Transcription Factors
Chemicals
Carrier Proteins Cell Cycle Proteins DNA-Binding Proteins E2F Transcription Factors E2F1 Transcription Factor E2F1 protein, human Nuclear Proteins Retinoblastoma Protein Retinoblastoma-Binding Protein 1 Trans-Activators Transcription Factor DP1 Transcription Factors DNA Acetyltransferases Histone Acetyltransferases p300-CBP Transcription Factors p300-CBP-associated factor Histone Deacetylases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Martínez-Balbás M A
Wellcome/CRC Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Bauer U M
Nielsen S J
Brehm A
Kouzarides T
References (56)
56 references, click to expand
  1. A direct link between core histone acetylation and transcriptionally active chromatin.
    EMBO J. 1988 May;7(5):1395-402 PMID: 3409869
  2. Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase.
    EMBO J. 1999 Aug 2;18(15):4280-91 PMID: 10428966
  3. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Nature. 1992 Jan 9;355(6356):176-9 PMID: 1530885
  4. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.
    EMBO J. 1992 Jul;11(7):2603-10 PMID: 1385776
  5. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.
    Cell. 1992 Jul 24;70(2):337-50 PMID: 1638634
  6. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
    Cell. 1992 Jul 24;70(2):351-64 PMID: 1638635
  7. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Science. 1992 Oct 16;258(5081):424-9 PMID: 1411535
  8. A new component of the transcription factor DRTF1/E2F.
    Nature. 1993 Mar 4;362(6415):83-7 PMID: 8446173
  9. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6914-8 PMID: 8346196
  10. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
    Nature. 1993 Sep 23;365(6444):349-52 PMID: 8377827
  11. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro.
    Nucleic Acids Res. 1993 Nov 11;21(22):4998-5004 PMID: 8255752
  12. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control.
    Trends Biochem Sci. 1994 Mar;19(3):108-14 PMID: 8203017
  13. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Cell. 1994 Nov 18;79(4):573-82 PMID: 7954824
  14. Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
    Genes Dev. 1994 Aug 1;8(15):1772-86 PMID: 7958856
  15. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Mol Cell Biol. 1994 Dec;14(12):8420-31 PMID: 7969176
  16. In vivo association of E2F and DP family proteins.
    Mol Cell Biol. 1995 May;15(5):2536-46 PMID: 7739537
  17. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
    Nature. 1995 Jun 22;375(6533):691-4 PMID: 7791903
  18. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Nature. 1995 Jun 29;375(6534):812-5 PMID: 7596417
  19. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
    Genes Dev. 1995 Dec 1;9(23):2873-87 PMID: 7498785
  20. Regulation of the cyclin E gene by transcription factor E2F1.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12146-50 PMID: 8618861
  21. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint.
    Cell. 1995 Dec 29;83(7):1149-58 PMID: 8548802
  22. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.
    EMBO J. 1995 Dec 15;14(24):6184-92 PMID: 8557038
  23. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
    Mol Cell Biol. 1996 Mar;16(3):1047-57 PMID: 8622649
  24. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP.
    Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1439-42 PMID: 8643650
  25. Tumor induction and tissue atrophy in mice lacking E2F-1.
    Cell. 1996 May 17;85(4):537-48 PMID: 8653789
  26. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
    Adv Cancer Res. 1996;68:67-108 PMID: 8712071
  27. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Nature. 1996 Jul 25;382(6589):319-24 PMID: 8684459
  28. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal.
    J Cell Sci. 1996 Oct;109 ( Pt 10):2443-52 PMID: 8923205
  29. The CBP co-activator stimulates E2F1/DP1 activity.
    Nucleic Acids Res. 1996 Nov 1;24(21):4139-45 PMID: 8932363
  30. The transcriptional coactivators p300 and CBP are histone acetyltransferases.
    Cell. 1996 Nov 29;87(5):953-9 PMID: 8945521
  31. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.
    Genes Dev. 1996 Dec 1;10(23):2949-59 PMID: 8956996
  32. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
    Genes Dev. 1996 Dec 1;10(23):2960-70 PMID: 8956997
  33. The CBP co-activator is a histone acetyltransferase.
    Nature. 1996 Dec 19-26;384(6610):641-3 PMID: 8967953
  34. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
    Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2221-6 PMID: 9122175
  35. The subcellular localization of E2F-4 is cell-cycle dependent.
    Proc Natl Acad Sci U S A. 1997 May 13;94(10):5095-100 PMID: 9144196
  36. Specific regulation of E2F family members by cyclin-dependent kinases.
    Mol Cell Biol. 1997 Jul;17(7):3867-75 PMID: 9199321
  37. Acetylation of general transcription factors by histone acetyltransferases.
    Curr Biol. 1997 Sep 1;7(9):689-92 PMID: 9285713
  38. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
    Cell. 1997 Aug 22;90(4):595-606 PMID: 9288740
  39. Histone acetylation in chromatin structure and transcription.
    Nature. 1997 Sep 25;389(6649):349-52 PMID: 9311776
  40. Subunit composition determines E2F DNA-binding site specificity.
    Mol Cell Biol. 1997 Dec;17(12):6994-7007 PMID: 9372931
  41. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Oncogene. 1997 Nov 27;15(22):2643-58 PMID: 9400991
  42. Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors.
    J Cell Sci. 1997 Nov;110 ( Pt 22):2819-31 PMID: 9427290
  43. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Nature. 1998 Feb 5;391(6667):597-601 PMID: 9468139
  44. Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
    Nature. 1998 Feb 5;391(6667):601-5 PMID: 9468140
  45. Rb interacts with histone deacetylase to repress transcription.
    Cell. 1998 Feb 20;92(4):463-73 PMID: 9491888
  46. Control of pRB phosphorylation.
    Curr Opin Genet Dev. 1998 Feb;8(1):21-7 PMID: 9529601
  47. Regulation of cell proliferation by the E2F transcription factors.
    Curr Opin Genet Dev. 1998 Feb;8(1):28-35 PMID: 9529602
  48. E1A directly binds and regulates the P/CAF acetyltransferase.
    EMBO J. 1998 Aug 3;17(15):4469-77 PMID: 9687513
  49. The regulation of E2F by pRB-family proteins.
    Genes Dev. 1998 Aug 1;12(15):2245-62 PMID: 9694791
  50. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases.
    Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9855-60 PMID: 9707565
  51. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.
    Mol Cell. 1998 Oct;2(4):457-67 PMID: 9809067
  52. Regulation of activity of the transcription factor GATA-1 by acetylation.
    Nature. 1998 Dec 10;396(6711):594-8 PMID: 9859997
  53. Regulation of endogenous E2F1 stability by the retinoblastoma family proteins.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2858-63 PMID: 10077601
  54. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP.
    Genes Dev. 1999 Mar 15;13(6):666-74 PMID: 10090723
  55. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.
    Cell. 1999 Apr 2;97(1):53-61 PMID: 10199402
  56. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.
    Cell. 1991 Jun 14;65(6):1063-72 PMID: 1828393
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2000-02-15
Pages
662-71
Language
English
Region
England
NLM ID
8208664
PMCID
PMC305604
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com